Drug Delivery
Overview
Drug Delivery is a peer-reviewed journal that focuses on the latest advancements in the field of drug delivery systems. It covers a wide range of topics including novel drug delivery technologies, formulation strategies, targeted drug delivery, nanomedicine, and controlled release systems. The journal provides a platform for researchers, scientists, and practitioners to share their innovative research and insights in the field of drug delivery, ultimately aiming to improve therapeutic outcomes and patient care.
Details
Details
Abbr.
Drug Deliv
Start
1993
End
Continuing
Frequency
Bimonthly, 2004-
p-ISSN
1071-7544
e-ISSN
1521-0464
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 3387
95
SJR / Ranks: 3004
1155
CiteScore / Ranks: 1928
8.70
JIF / Ranks: 1121
6.0
Recent Articles
1.
Vitek M, Zvonar Pobirk A, Roskar R, Matjaz M
Drug Deliv
. 2025 Mar;
32(1):2460708.
PMID: 40066714
The fast-growing filed of long-acting depots for subcutaneous (SC) administration holds significant potential to enhance patient adherence to treatment regimens, particularly in the context of chronic diseases. Among them, injectable...
2.
Story B, Park S, Roszak K, Shim J, Motta M, Ferneding M, et al.
Drug Deliv
. 2025 Mar;
32(1):2460671.
PMID: 40038090
A clinical need exists for more effective intravitreal (IVT) drug delivery systems (DDS). This study tested the hypothesis that a novel biodegradable, injectable microsphere-hydrogel drug delivery system loaded with aflibercept...
3.
Rafiei M, Shojaei A, Chau Y
Drug Deliv
. 2025 Mar;
32(1):2465909.
PMID: 40028722
Regulating inflammatory microglia presents a promising strategy for treating neurodegenerative and autoimmune disorders, yet effective therapeutic agents delivery to these cells remains a challenge. This study investigates modified lipid nanoparticles...
4.
Elkhashab M, Barreto G, Fauconnier M, Le Bourlout Y, Creemers L, Nieminen H, et al.
Drug Deliv
. 2025 Feb;
32(1):2464921.
PMID: 39967271
Objective: Antisense oligonucleotides (ASOs) have reached the clinic; however, they lack tissue specificity. Albumin is a plasma-abundant macromolecule that has been shown to accumulate in inflamed tissues. In this work,...
5.
Kurabi A, Sereno E, Ryan A
Drug Deliv
. 2025 Feb;
32(1):2463427.
PMID: 39960246
The tympanic membrane (TM) forms an impenetrable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare...
6.
Zhang M, Zhang R, Feng C, Jiang X, Xu X, Wang J
Drug Deliv
. 2025 Feb;
32(1):2464190.
PMID: 39957241
The clinical treatment of rheumatoid arthritis (RA) with first-line therapeutic drugs is hindered by the poor solubility, low bioavailability, off-target toxicity, and insufficient accumulation in inflamed joints. Liposomes have been...
7.
Zhang Z, Wang J, Li X, Zhao L, Zhao J, Su M, et al.
Drug Deliv
. 2025 Feb;
32(1):2464189.
PMID: 39957204
Celastrol (Cel) is a potential anticancer therapeutic candidate, but its limited practical applicability is due to its low solubility, poor tumor selectivity, and cytotoxicity. Clinically, ginsenoside Rg3 (RG3) is typically...
8.
Pharmacokinetic profile and anticancer efficacy of anagrelide administered subcutaneously in rodents
Toivanen K, Sutter L, Wozniak A, Wyns K, Merikoski N, Salmikangas S, et al.
Drug Deliv
. 2025 Feb;
32(1):2463433.
PMID: 39930717
Anagrelide (ANA) is a phosphodiesterase 3A (PDE3A) inhibitor, commonly prescribed for essential thrombocythemia. It also functions as a molecular glue, inducing complex formation between PDE3A and Schlafen 12. This association...
9.
Ghanem R, Buin X, Haute T, Philippe J, Kaouane G, Leclerc L, et al.
Drug Deliv
. 2025 Feb;
32(1):2463428.
PMID: 39930696
Nanoparticles-based gene delivery has emerged as a promising approach for the treatment of genetic diseases based on efficient delivery systems for therapeutic nucleic acids (NAs) into the target cells. For...
10.
Jurgelane I, Egle K, Grava A, Galkina D, Brante M, Melnichuks M, et al.
Drug Deliv
. 2025 Feb;
32(1):2460666.
PMID: 39916297
Cannabidiol (CBD) is recognized for its therapeutic properties in various conditions. However, CBD's limited water solubility and sensitivity to environmental stresses hinder its efficacy and bioavailability. Encapsulation in drug delivery...